Waeijen-Smit, Kiki
Reynaert, Niki L.
Beijers, Rosanne J. H. C. G.
Houben-Wilke, Sarah
Simons, Sami O.
Spruit, Martijn A.
Franssen, Frits M. E.
Funding for this research was provided by:
AstraZeneca and the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health (LSHI19003)
Article History
Received: 8 April 2021
Accepted: 20 July 2021
First Online: 5 August 2021
Competing interests
: Drs. Waeijen-Smit, Dr. Houben-Wilke, Dr. Reynaert, Dr. Beijers and prof. Spruit declare no competing interests. Dr. Franssen reports grants and personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from GlaxoSmithKline, grants and personal fees from Novartis, personal fees from TEVA, outside the submitted work. Dr. Simons reports grants and personal fees from AstraZeneca, grants from Boehringer Ingelheim, personal fees from Chiesi, grants and personal fees from GlaxoSmithKline, all outside the submitted work.